Zoliprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C12H11NO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J2GC047H27, chemically known as propionic acid, 2-(p-((2-thiazolyl)oxy)phenyl)- but generally known as zoliprofen, which bears US NIH Compound Identifier 68758. European Medicines Agency schedules Zoliprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00180MIG. The term ZOLIPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). ZOLIPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zoliprofen under HS 29341000 and SITC 51579. As of Q4 2014, ZOLIPROFEN remains the US FDA Preferred Term for this commodity. Zoliprofen bears US NLM identifiers UMLS ID C1883609 and NCI Concept Code C66706. SMILES: CC(C1=CC=C(C=C1)OC2=NC=CS2)C(=O)O.